Introduction
The mother, placenta and the fetus are functionally and anatomically integrated but the interplay between the parts of this fetomaternal unit is difficult to study. In prenatal pharmacology, toxicology, reproductive endocrinology and in nutritional research the events in and the interplay between the tissues are of particular interest to study. A noninvasive technique which gives sequential information on the transfer of substances across the placenta is therefore a great value.
Positron emission tomography (PET) is a new technique which has been introduced during the last few years for in vito studies of pharmacological, physiological and biochemical processes in the living body. We have employed and introduced the PET technique in experimental perinatal medicine. Our studies so far have been performed in the feto-maternal unit of Rhesus monkeys and focused on two important problems: the kinetics of placental transfer and protein incorporation of the amino acid n C-methionine, the uptake and fetal kinetics of morphine and heroin which are sometimes abused by pregnant women.
Particular emphasis is given to the methodological aspects of the technique while the original results are presented elsewhere in detail [2, 12] . Advantages and shortcomings of the PET technique will also be discussed, as well as the application of the method to pharmacokinetic studies of drugs and nutritients in the mother and fetus.
Positron emission tomography
A positron emission tomographic experiment comprises three steps: production of ra- ionucleides, synthesis of "C-labelled ra-to the Rhesus monkey the samples were filtered diotracer and investigation by positron emis-through 0.22 μπι membrane filters. The dose of sion tomography. Most positron emitters have radiolabelled drug varied between 19-93 MBq a rapid physical decay. Thus, the half-life of for "C-morphine and "C-heroin and 110-370 n C is only 20.4 minutes.
MBq for "C-methionine. In some experiments _. , r 11^ j *ι_ the radiolabelled dose was given together with The decay of «C produces a positron, the an-& dose of ^ unlabdled analogue . tiparticle of an electron. The positron is thermalized within a mm from the spot of decay in In the organic chemical preparation of the rathe tissue. The positron mass and an electron diolabelled tracers the time factor is as importmass are annihilated forming two antiparallel ant as the reaction yield. This is due to the photons which are recorded by external de-rapid decay of J1 C and therefore a minimum of tectors. The data collected are utilized for re-time should elapse from the production of construction of images, representing the ran CO2 to the administration of the radiolabelled dionucleide distribution in transaxial slices of compound. The time used including organic the body by use of standard computerized re-synthesis, purification by liquid chroconstruction principles. The three steps are de-matography and sterilization of the product did scribed in more detail below.
never exceed 60 minutes.
Radionucleide production 2.3 Animals
The production of radionucleides was per-Healthy well-nourished pregnant Rhesus monformed at the Tandem Laboratory, University keys (Macaca mulatta) from the Primate Labof Uppsala.
1J
C was produced by bombardment oratory of Reproductive Research in Uppsala of nitrogen gas with protons (HMeV, 15 μΑ). were used in the study. The age of the animals In this method the nascent U C atoms react with ranged between 7 and 15 years, and their weight trace amounts of oxygen present in the target was between 7.3 and 9.1 kg. gas forming mainly* 1 CO2. Th f ^T ^ *?' synthesis esthetized with ketamme L M., and anesthesia was maintained with repeated doses of 50 -100 mg of ketamine. Two indwelling catheters were 2.2 Organic chemistry inserted in <^ηί leg veins one for administration of the dose, the other for blood The positron emitting radionucleide was used sampling. Catheters were also introduced into in the organic synthesis of the desired ra-the urinary bladder and into the amniotic cavdiolabelled compounds. The "COi from the ity, in the latter case by ultrasonic guidance, accelerator was converted in a series of steps During the course of the studies a new techto "C-methyl iodide [17, 18] . The "C-methyl nique for sampling of fetal blood was iodide was used in methylation reactions of employed. The umbilical vein was punctured homocysteine and the N-demethylated ana-by a thin needle under the guidance of ullogues of morphine and heroin, respectively, trasonography [13] . The monkey, was fixed in Samples of the * ^-methylated compound were a specially designed cradle in the positron emisisolated and analyzed with respect to their iden-sion tomograph so thai the fetal liver and one tity and radiochemical purity. Radiochemical placenta were monitored simultaneously. All purity was always above 98 per cent and the experiments were carried out after approval of enantiomericpurityofLandDmethioninewas the Committee for Protection of Laboratory above 99 per cent [2, 8] . Before administration Animals at the University of Uppsala. 
Positron emission tomography (PET)
Immediately after administration of the U Clabelled compound imaging of the monkey started. Two antiparallel photons, formed from the annihilation are detected by two opposing detectors fitted in a ring of detectors. A computer controls the detector channels and calculates the distribution of radioactivity in a section of the object defined by the plane of detector rings. The two basic ideas of positron emission are: radionucleide distribution is detected and quantified outside the body; and the co-incidental detection in two opposing detectors in the ring gives an accurate information about the location of radioactivity [3] . A Scanditronix PC 384-3B positron emission tomograph (AB Scanditronix, Uppsala, Sweden) was used. It is equipped with two rings of detectors (96 in each ring) giving three simultaneous images with a slice thickness of 13 -14 mm and a resolution of 8mm. Data collection and analyses were performed as described by ERIKSSON et al. [6] . A predetermined program was used to record images for 12, 40 and 200 sec until the end of the investigation.
Evaluation of PET images
After image reconstruction it is possible to delineate an organ or a part of an organ. The computer quantitates the radioactivity corrected for physical decay per unit of volume in the regions of interest. As the administered radioactivity and the body weight of the monkey are known, a measure denoted "uptake" is calculated. This is defined as nCi per cm 3 of tissue, divided by the dose in nCi per gram of body weight. An uptake value of 1.0 corresponds to an uptake as if the administered radioactivity was homogeneously distributed in the body of the monkey. The following regions of interests were delineated: fetal liver, placenta, maternal paraspinal muscle and aorta.
Pharmacokinetic analysis
Although PET by itself is non-invasive, additional information may be obtained by complimentary techniques. Samples of maternal urine, blood and amniotic fluid were thus collected at regular intervals after dose and counted for total radioactivity in a well counter (Nal [Tl] ). Radioactivity uptake, as defined above, was measured in blood and amniotic fluid.
Blood samples were centrifuged and the 11 Cmethionine derived radioactivity in the high molecular fraction was measured after gel filtration on Sephadex G25 with saline as mobile phase [16] .
In the case of morphine and heroin, the unlabelled drug and the major plasma metabolite, morphine-3-glucuronide (M3G), were analyzed in plasma and amniotic fluid by means of high performance liquid chromatography [19] .
Possibilities and shortcomings of PET

Applications of PET
Positron emission tomography is a non-invasive tracer technique which may be used to measure the kinetics of physiological or biochemical processes in animals or man. Pharmacological studies are often aimed at the study of the interaction in physiological mechanisms by drugs or endogenous compounds. Thus, positron emission tomography provides unique opportunities to study the in vivo kinetics of drugs or the kinetics of incorporation of radiolabelled endogenous compounds in biochemical processes. As only trace amounts of the compound are given, no pharmacological effects are seen, and hence the kinetics can be studied during undisturbed, physiological conditions. In man, PET has been used in order to measure glucose utilization in the brain in mental disorders, delineate and grade gliomas or pituitary tumours after administration of different n Clabelled amino acids [4, 11, 15] and it has been used in studies of regional blood flow [1] . Studies have also been performed on the intracerebral distribution of the dopamine antagonist, H C-methyl-spiperone [20] , which reflects the dopamine receptor population in the human brain. Thus, e. g. it has been shown that the number of receptors decreases with age;
The human studies are often preceeded by experiments in animals to evaluate the organ distribution of the radiotracer and to determine its kinetics in the organ of interest.
Several pharmacokinetic studies have been performed in animals, since the use of PET as an autoradiographic in vivo technique will furnish pharmacologists and pharmacokineticists with data unavailable with other methods. Thus, the uptake and kinetics of narcotic analgesics [8] , opioid peptides [9] , and dopamine receptor antagonists [20] have been studied in different areas of the brain, as well as bromocriptine in the pituitary [15] . The binding of n C-labelled compounds in different areas of the brain enables one to study the nature of reversible, selective receptor binding and the mechanism of receptor displacement. The irreversible binding of N-methyl-tetra-hydropyridin to melanin containing cells in substantia nigra has thrown light upon the etiology of Parkinsons disease [14] . Distribution of opioids [7] and anesthetics after epidural or intrathecal administration may help to explain the mechanisms behind the late respiratory depression observed in man after spinal application of these drugs. Rapid physiological processes may be described which is of particular value in the studies of transfer of compounds from mother to fetus in pregnancy. Important studies on the extent and rate of transfer of nutrients and drugs [2, 12] from the mother to the fetus during pregnancy will be reported below.
This review of some applications gives avidence for the unique possibilities of PET to provide data which cannot be obtained with other techniques. Some shortcomings of the technique will limit its use and create difficulties in the interpretation of the results. These shortcomings may be circumvented by use of additional methods.
Shortcomings of PET
The positron tomograph used has a spatial resolution of 8 mm. This limits the possibilities to study small organs and areas of interest in fetuses. On the other hand, if the pharmacokinetics of the fetus are studied, the whole body kinetics can be integrated over time, as well as the kinetics in a sufficiently large organ such as the liver. The blood borne activity in vividly perfused organs may interfere with the evaluation of the radioactivity in the tissue. Therefore correction for the radioactivity in blood must be made. The blood volume can be estimated after administration of 68 Ga-EDTA or 68 GaCl2, which are distributed intravascularly to a high extent. It is thus possible to study the tissue kinetics after correction for the blood borne radioactivity.
In order to separate the ^C-derived activity from the metabolites from that of the parent drug, the PET may be complemented by chromatographic methods [8, 16] .
PET utilizes shortlived radio-isotopes as 15 O, 13 N and n C with a half-life of physical decay of minutes. Studies lasting more than 2 hours cannot be done. Autoradiography in small animals can complement the PET images [14] . The uptake of * ^-labelled tracer in different organs may also be compared with the radioactivity measured in a well counter from the whole organ obtained after sacrifice of the animal.
The short physical half-life of 1! C is an advantage, since the radiation dose will be small. Furthermore, repeated administration of H Clabelled drug in the same animal in the same experimental set up is possible. This means that the animal may serve as its own control when physiology is altered between experiments.
Interpretation of the results
Distribution and lipophilic property
The time for the drug to reach equilibrium in a well-perfused organ is determined by the blood flow and the distribution ratio of the drug between the tissue and blood. For the uptake in brain, the lipophilic property of the drug is a major determinant besides binding characteristics in plasma and tissue. The lipophilic property of a drug may be expressed as the distribution coefficient between octanol and buffer (pH = 7.4 at 37 °C). For opioid drugs, meperidine (pethidine) had the most rapid and extensive uptake in the brain followed by heroin, codeine and morphine in order of decreasing lipophilic properties [8] . A higher than expected uptake may indicate some kind of active transport which has been shown for 1! Cmethionine in the brain [4] , or it may indicate irreversible binding to structures in the brain as shown for N-phenyl-tetrahydropyridine [14] .
The PET images from a n C-heroin experiment are shown in Fig. 1 , where the uptake of radioactivity in placenta and fetal liver during the first 27 minutes of the experiment is seen. The uptake of heroin in the fetal liver was more than three times higher than for the more hydrophilic morphine [12] . Maximum uptake was also reached earlier with heroin.
The elimination rate of the * ^-derived radioactivity from the brain was in the same range for heroin and morphine. This is probably due to a rapid conversion of * ^-heroin to J1 Cmorphine. Therefore, after administration of 1 ^-heroin the late PET-images reflect the disposition of 1 ^-morphine in the fetus.
H C-methionine rapidly reached the fetus, probably by a facilitated transport system. It was also shown that the transport system was selective for the L-enantiomer of methionine at the expense of the D-form. 
Plasma protein binding
In the mother, morphine was rapidly converted to M3G. The transfer of morphine to the fetus An extensive plasma protein binding may limit was slow as was the fetal dispos i t i on of bo th the uptake of the »C-labelled compound in morpbine and M3G [12] . At 100 minutes foldifferent organs. Endogenous compounds such lowing administra tion the morphine and M3G as amino acids are also readily incorporated conce ntrations were higher in the fetus than in in the high molecular fraction in plasma [2] . ±e mothere This may re fl e ct the slow transfer However, the incorporation was selective and of hydrophilic metabolites across the placenta, discriminative for the D-form of "Omethionine. Determination of lipophilic properties and plasma protein binding of the 1 ^-labelled tracer is of great importance, not only in in-4.4 Pharmacokinetic modelling terpretation of the PET images, but also in _ -, 1 . -,.
. . the elucidation of the mechanism of different Because of low resolution, the radioactivity physiological processes. measured in the PET-images may derive from adjacent organs, and incorporation of ^-derived radioactivity in a physiological process may be hidden in the unselective uptake of the ity in the cerebellum from that in property and a high extent of non-selective other areas of the brain, the kinetics of the binding in the brain tissue may well give results receptor blndmg can be descnbed ™' which are similar to the blood kinetics of the For more sophisticated analysis a compartment n C-tracer [10] . Blood kinetics cannot be studied model is required. Such a model for the fetoby PET because of the radiation from tissues maternal unit is depicted in Fig. 2 . By esand from drug metabolites. Radiochemical or timation of the value of the rate constants, the chemical analyses of * ^-labelled drug or unla-kinetics in maternal and fetal plasma of a drug belled drug and metabolites in plasma may or an amino acid can be simulated. The results solve this problem and are performed by means are given in Fig. 3 for morphine which was of sensitive and selective Chromatographie given to a pregnant Rhesus monkey. A certain methods [8, 16] .
resistance to transfer across the placenta was Valuable pharmacokinetic data are obtained f s^fd · After ™rti<» of the measured values from the urine, amniotic fluid and even fetal from the matemal ™ d^ P la *ma the different blood [13] . After administration of "Conorrate constants can be determined, phine together with 14 C-morphine and unla-By extending the compartment analysis to other belled morphine-3-glucuroriide (M3G) to two compartments such as maternal urine and ampregnant Rhesus monkeys, the concentrations niotic fluid and inclusion of the data for the of morphine and M3G were measured in plas-main metabolites of morphine, M3G, one may ma, maternal urine, and amniotic fluid [12] . further strengthen the interpretation of the One fetal blood sample was also available.
transfer mechanisms in the feto-maternal unit. . Simulation was made with the pharmacokinetic computer program DARE-P at UDAC at the University of Uppsala.
The model can be employed for all kinds of compounds and by inclusion of PET data a full description of the kinetics is obtained.
Conclusions
The PET technique is based on several sciences e. g. physics, radiobiology, organic chemical synthesis, pharmacology, pharmacokinetics, radiology and several clinical disciplines. The number of people involved in a PET-experiment is in the order of 4 -8. The high costs of the method may hamper its further development in experimental pharmacology.
PET has many applications but one of its major impacts has been in studies on the kinetics and transfer mechanisms in the feto-maternal unit. Because of its non-invasive character, the PET methodology gives information which are unavailable by other techniques. Since studies are performed in the Rhesus monkey the results may be extrapolated to man. The placental transfer mechanisms are studied by pharmacokinetic modelling, which support the interpretation of the results. The presented method is of interest in studies of develop mental pharmacology in the feto-placental unit and is applicable to several types of compounds, including nutrients and drugs ingested or abused by the mother.
Summary
Positron emission tomography (PET) is a new tracer technique by which short-lived radionucleides, such as n C are used for labelling drugs, amino acids and other compounds. The concentration in the various organs is determined non-invasively after I.V. injection. Positrons, emitted by n C attract an electron, and the two masses are annihilated by emitting photons. These can be registered by external detectors. Measurement of the radioactivity per volume of tissue as a function of time is accomplished by computerized processing of the data. The PET technique may be used for studies of the kinetics of the injected compound in different organs of the body. However, PET registers only the total radioactivity meaning that the measured * ^-radioactivity represents the sum of the parent compound and the radiolabelled metabolites. Chemical and radiochemical analyses in various body fluids may then help to interpret the PET images.
The major use of PET has been in studies of metabolism and receptor binding in the brain. The present paper is a review of the PET technique as used in experimental perinatal medicine.
We have employed PET in kinetic studies of methionine in the fetomaternal unit of Rhesus monkeys. After I. V. injection of n C-L-or D-methionine, the distribution of radioactivity in maternal muscles, placenta and fetal liver were registered. There was a rapid transport of n Cactivity to the fetal compartments after administration of the two enantiomers. By analyses of the radioactivity in maternal plasma after gel separation, it was found that only the L-form was used in the protein synthesis. PET is thus suitable for studies of stereospecific kinetics and metabolism of amino acids in the feto-maternal unit. In another project, the kinetics of the opiates 1 ^-morphine and 1! C-heroin were studied in pregnant Rhesus monkeys. The opiates were rapidly metabolized why the PET images had to be complemented by analyses of samples from maternal blood, urine, and amniotic fluid. Fetal blood was also obtained through puncture of the umbilical vein. Both i ^-morphine and * ^-heroin were rapidly transported to the fetus. The heroin derived "C-activity in the fetal liver was almost three times higher than that of ^-morphine, which may reflect the difference in lipophilic property between these drugs. The concentration of morphine in fetal blood was twice that in maternal blood after 100 min. Data from PET studies of morphine in the feto-maternal unit were used in the simulation of pharmacokinetic compartment models/ Such simulation may aid in the 'interpretation of results from PET studies, and eliminate the need for additional analyses of body fluids. Thus, the non-invasive character of PET implies a great potential for studies in experimental perinatal medicine. Nous avons employe la T. E. P. dans les etudes cinetiques de la methionine dans Funite foeto-maternelle de singes Rhesus. On a enregistre la distribution de la radioactivite dans les muscles maternels, le placenta et le foie foetal apres injection I. V. de 11 C. L. ou D. methionine. II y a un transport rapide de Pactivite 11 C vers les compartiments foetaux apres administration des deux enantiomeres. En analysant la radioactivite sur gel, on a trouve que seule la forme L est utilisee pour la synthese proteique. Ainsi, la T. E. P. est appropriee pour les etudes des cinetiques stereo-spccifiques et du metabolisme des acides amines dans Punite foeto-maternelle. Dans un autre projet, les cinotiques des opiaces morphine 11 C et heroine 11 C ont etc etudices chez des guenons rhesus gravides. Les opiaces sont rapidement motabolisos c'est pourquoi les images de T. E. P. doivent etre completees par Panalyse d'echantillons de sang maternel, d'urine et de liquide amniotique, on a egalement obtenu du sang foetal par ponction de la veine ombilicale. La morphine 11 C et Pherome 11 C sont rapidement transportos vers le foetus. Uactivitc 11 C dans le foie foetal, en provenance de Pherome est presque trois fois plus 61evee que celle derivant de la 11 C morphine, ce qui peut rcflcter la difference de lipophilie entrc ces substances. Les concentrations de morphine dans le sang foetal sont le double de celles du sang malernel au bout de 100 minutes. Les donnees tiroes des etudes avec T. E. P. de la morphine dans 1'unito foeto-maternelle ont etc utilisees pour la simulation de modeles de compartiments pharmacocinetiques. De telles simulations peuvent aider Pinterpretation des rcsultats provenant des etudes de T. E. P. et eliminer la necessite d'analyses complementaires des liquide de Porganisme. Ainsi, le caractere non invasif de la T. E. R souligne son vaste potentiel pour les etudes concernant la medecine perinatalc cxperimentale.
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